Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Sung Gyun | - |
dc.contributor.author | Lee, Jun-Won | - |
dc.contributor.author | Kang, Dae Ryong | - |
dc.contributor.author | Kim, Hye Sim | - |
dc.contributor.author | Go, Tae-Hwa | - |
dc.contributor.author | Yu, Min Heui | - |
dc.contributor.author | Kim, Ju Han | - |
dc.contributor.author | Jun, Myung Ho | - |
dc.contributor.author | Park, Jong-Seon | - |
dc.contributor.author | Chae, Shung Chull | - |
dc.contributor.author | Cho, Myeng-Chan | - |
dc.contributor.author | Kim, Chong Jin | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Kim, Hyo-Soo | - |
dc.contributor.author | Seung, Ki Bae | - |
dc.contributor.author | Cha, Kwang Soo | - |
dc.contributor.author | Chae, Jei Keon | - |
dc.contributor.author | Joo, Seung Jae | - |
dc.contributor.author | Rha, Seung Woon | - |
dc.contributor.author | Choi, Dong-Ju | - |
dc.contributor.author | Hur, Seung Ho | - |
dc.contributor.author | Seong, In Whan | - |
dc.contributor.author | Kim, Doo Il | - |
dc.contributor.author | Oh, Seok Kyu | - |
dc.contributor.author | Ahn, Tae Hoon | - |
dc.contributor.author | Hwang, Jin Yong | - |
dc.contributor.author | Yoon, Junghan | - |
dc.date.accessioned | 2021-09-01T17:59:32Z | - |
dc.date.available | 2021-09-01T17:59:32Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 0954-6928 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/67078 | - |
dc.description.abstract | Background The safety and efficacy of immediate multivessel coronary intervention (MVI) remain controversial in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease (MVD). This study aimed to investigate the clinical outcomes of immediate MVI compared with culprit-vessel intervention only (CVI-O) in diverse subgroups with STEMI and MVD. Patients and methods We compared immediate MVI (n = 260) and CVI-O (n = 931) regarding 1-year major adverse cardiac event rates for cardiac death, recurrent myocardial infarction (MI), and repeat revascularization in 1191 STEMI patients with MVD using data from the Korea Acute Myocardial Infarction-National Institutes of Health registry (2011-2015). High-risk patients and those who underwent a staged procedure were excluded from the analysis. Furthermore, propensity score matching and stratified subgroup analyses were performed. Results Immediate MVI and CVI-O groups had similar 1-year major adverse cardiac event rates [7.7 vs. 8.9%, hazard ratio (HR): 0.86, 95% confidence interval (CI): 0.50-1.47, log-rank P = 0.5628]. No difference was found between the groups in terms of the 1-year rate of cardiac death (2.9 vs. 1.3%, HR: 2.24, 95% CI: 0.75-6.67) or recurrent MI (2 vs. 1.5%, HR: 1.41, 95% CI: 0.45-4.44). However, repeat revascularization occurred less frequently in the immediate MVI group than in the CVI-O group (2.0 vs. 5.7%, HR: 0.35, 95% CI: 0.13-0.90, log-rank P = 0.0142). These findings were found to be consistent across a broad spectrum of subgroups. Conclusion Compared with CVI-O, immediate MVI did not improve 1-year net clinical outcomes in stable STEMI patients with MVD. The only benefit found was a reduced repeat revascularization in immediate MVI. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | SEGMENT ELEVATION | - |
dc.subject | COMPLETE REVASCULARIZATION | - |
dc.subject | RANDOMIZED-TRIAL | - |
dc.subject | TASK-FORCE | - |
dc.subject | ANGIOPLASTY | - |
dc.subject | ASSOCIATION | - |
dc.subject | MANAGEMENT | - |
dc.subject | LESION | - |
dc.title | Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung Woon | - |
dc.identifier.doi | 10.1097/MCA.0000000000000684 | - |
dc.identifier.scopusid | 2-s2.0-85060919200 | - |
dc.identifier.wosid | 000480683400004 | - |
dc.identifier.bibliographicCitation | CORONARY ARTERY DISEASE, v.30, no.2, pp.95 - 102 | - |
dc.relation.isPartOf | CORONARY ARTERY DISEASE | - |
dc.citation.title | CORONARY ARTERY DISEASE | - |
dc.citation.volume | 30 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 95 | - |
dc.citation.endPage | 102 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | SEGMENT ELEVATION | - |
dc.subject.keywordPlus | COMPLETE REVASCULARIZATION | - |
dc.subject.keywordPlus | RANDOMIZED-TRIAL | - |
dc.subject.keywordPlus | TASK-FORCE | - |
dc.subject.keywordPlus | ANGIOPLASTY | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | LESION | - |
dc.subject.keywordAuthor | multivessel disease | - |
dc.subject.keywordAuthor | revascularization | - |
dc.subject.keywordAuthor | ST-elevation myocardial infarction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.